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Trichorhinophalangeal syndrome (TRPS) is an autosomal dominantly inherited condition caused 
by heterozygous mutations of the TRPS1 gene. This gene codes for the GATA transcriptional 
factor TRPS1. Patients with TRPS exhibit multiple skeletal, hair, dental and craniofacial defects, 
including cleft palate. Using mouse models, one of the goals of this study is to characterize the 
skeletal abnormalities of Trps1-deficient mice. Skeletal staining using Alcian blue/Alizarin red 
revealed apparent underdevelopment of the zygomatic arch, sternum, vertebrae and anterior 
cranial base in Trps1-/- mice. We also found that the nose and mandible of Trps1-/- mice were 
significantly shorter. Additionally, cleft palate was detected in Trps1-/- mice. In order to 
understand the role of Trps1 in palatogenesis, immunohistochemistry was used to delineate the 
expression pattern of Trps1 protein in wildtype (WT) mouse tissues. We demonstrated that Trps1 
was expressed in palatal shelf mesenchyme and epithelium, specifically at the medial edge 
epithelium. Along the anterior-posterior axis, epithelial Trps1 signal appeared to be increased in 
the posterior region of the palate. Lack of fusion observed in Trps1-/- mouse palatal shelves led 
us to examine proteins involved in the fusion process. Thus, immunohistochemistry was used to 
compare the expression of Tgfβ3, Twist1, and β-catenin in WT and Trps1-/- mice. Tgfβ3, β-
catenin and Twist1 were all expressed in WT palatal epithelium as well but were downregulated 
in Trps1-/- palatal epithelium. In summary, Trps1 plays a vital role in proper skeletal and 
craniofacial development, including palatal shelf fusion. Trps1 is also involved in the regulation 
of other proteins required for palatal fusion. 
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1.0  INTRODUCTION 
1.1 CLEFT LIP AND/OR PALATE 
Cleft lip and/or palate (CL/P) is one of the most common birth defects in North America and it 
occurs in approximately 1 out of every 700 live births (Dixon et al. 2011). According to the 
Centers for Disease Control and Prevention (CDC), there are approximately 4440 new cases of 
CL/P per year in the United States (Parker et al. 2010). CL/P may occur bilaterally or unilaterally 
with a predilection for the left side (Mastroiacovo et al. 2011). It may also present as an isolated 
defect or as part of another disorder, thus referred to as non-syndromic or syndromic CL/P, 
respectively.  
The emotional stress endured by CL/P patients and their families can be dramatic. This 
issue was highlighted in a study showing that 30% of mothers of affected children have 
contemplated suicide (Natsume et al. 2013). The treatment of CL/P involves multiple surgeries 
to establish proper function and esthetics, which can further add onto the financial and 
psychological burden of the patients and their families. Furthermore, the costs inflicted on the 
health care industry are substantial as the CDC estimated that the lifetime expense of treating 
CL/P patients per year is $679 million (National Institute of Dental and Craniofacial Reasearch 
2018). Therefore, it is imperative that research in this field focuses on optimizing the 
management of patients with orofacial clefts in order to minimize these stresses.  
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The care of patients with CL/P is complex and involves numerous sessions with a variety 
of specialists, including but not limited to oral surgeons, orthodontists, pediatrics, 
prosthodontists, psychologists, plastic surgeons, and speech therapists. These patients often must 
undergo multiple surgical procedures starting from infancy to adulthood. The typical treatment 
protocol includes early lip repair within the first postnatal year and palatal reconstruction before 
speech develops at approximately 12 to 18 months. Placement of bone graft at the cleft site 
should be delayed until the adjacent teeth are ready to erupt, typically at 7 to 9 years old. 
Orthodontic treatment is often required to correct any malocclusion and prosthetic replacement 
of missing teeth may be necessary. Severe skeletal discrepancies are corrected with orthognathic 
surgery near the end of the patient’s growth at around 15 to 18 years old and final soft tissue 
revisions, including rhinoplasty, is done at the final stage after the completion of nasal growth 
(American Cleft Palate-Craniofacial Association 1993). 
Currently, the gold standard for CL/P treatment remains surgical repair. However, the 
procedure can be physically and emotionally demanding as we have previously discussed. There 
are also co-morbidities associated with autogenous bone grafts in surgical cleft repair, including 
pain, infection, bleeding, nerve damage, and donor bone fracture (Tavakolinejad et al. 2014). 
Other therapeutic options that have been explored include tissue engineering using stem cells 
from bone marrow or adipose tissue, which has significantly less morbidities than traditional 
grafting techniques (Gimbel et al. 2007; Panetta et al. 2008; Pourebrahim et al. 2013). More 
novel approaches involve in utero molecular therapy to deliver signaling molecules to mouse 
embryos for prenatal cleft palate correction (Wu et al. 2013; Jia et al. 2017). The innovation of 
molecular therapies aimed at preventing cleft palates before birth can significantly reduce the 
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financial and social burdens discussed and has great potential in advancing the craniofacial 
regeneration field. 
1.2 PALATOGENESIS 
In order to gain insight on these molecular therapies, one must first understand the process of 
normal palatal development, also known as palatogenesis. Palatogenesis has been studied 
extensively using mouse models because mouse and human palatal development are highly 
comparable. During normal development, the primary and secondary palates arise from the 
medial nasal and maxillary process, respectively. These early stage palatal shelves grow 
vertically downwards on either side of the tongue (Figure 1.1A). As development progresses, the 
palatal outgrowths elevate and reorient themselves horizontally above the tongue (Figure 1.1B). 
Following palatal shelf elevation, cell proliferation allows the medial edge epithelium (MEE) of 
the two palatal shelves to approximate each other at the midline. Once the palatal shelves make 
contact, cell adhesion occurs and a resultant midline epithelial seam (MES) is formed (Figure 
1.1C). The MES subsequently disintegrates to allow for mesenchymal confluency in a process 
termed palatal fusion. There are three primary cellular mechanisms thought to be responsible for 
palatal shelf fusion: epithelial cell apoptosis, migration and transition to the mesenchymal state 
via the epithelial-to-mesenchyme transition (EMT) process (Bush and Jiang 2012). A disruption 
at any stage of this complicated process can result in a cleft palate. 
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Figure 1.1. Stages of palatogenesis in mouse embryo. A) Vertical palatal shelf growth. B) Palatal shelf elevation. 
C) Formation of midline epithelial seam. Scale bar 100μm. PS- palatal shelf; T- tongue. (unpublished) 
 
1.3 GENETIC REGULATION OF PALATOGENESIS 
Palatogenesis may be disrupted by a multitude of genetic and environmental factors. This 
complex process is tightly controlled by numerous interactions between epithelial and 
mesenchymal cells within the palatal shelves. Several signaling pathways are involved at each 
stage of development, including sonic hedgehog (Shh), fibroblast growth factor (Fgf), bone 
morphogenetic protein (Bmp), transforming growth factor beta (Tgfβ), Twist1, and Wnt/β-
catenin pathway. Shh is expressed specifically in oral epithelium and promotes cell proliferation 
and palatal outgrowth via its receptor Patched 1 (Ptc) (Rice et al. 2006; Lan and Jiang 2009). 
Fgf10 and Bmp2 both regulate cell proliferation within the palatal mesenchyme and also 
maintain a positive feedback loop with Shh to stimulate palatal outgrowth (Zhang et al. 2002; 
Rice et al. 2004; Lan and Jiang 2009; Baek et al. 2011). Tgfβ and Twist1 are key players in 
palatal fusion by regulating MES apoptosis and EMT (Martinez-Alvarez et al. 2000; Xu et al. 
2006; Yu et al. 2008). Finally, the Wnt/β-catenin pathway has been implicated in palatal shelf 
elevation and palatal fusion through its regulation of other signaling molecules (Yu et al. 2010; 
He et al. 2011). These examples serve to illustrate the intricate level of cross-communication 
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between multiple signaling pathways and between epithelial and mesenchymal cells to ensure 
proper palatal development. Amongst all the cellular mechanisms at play, an interruption at any 
level can lead to a cleft palate. By identifying the defective pathways, it is possible to work 
towards an intervention targeting specific pathways to recover lost cellular function. 
1.3.1 Epithelial-to-mesenchyme transition (EMT) regulation 
Epithelial-to-mesenchymal transition (EMT) is a cellular process that occurs during both normal 
development and pathological conditions where an epithelial cell transforms into a mesenchymal 
cell. However, this process is reversible through mesenchymal-to-epithelial transition (MET). 
Epithelial cells are tightly connected to each other through gap junctions while mesenchymal 
cells are loosely organized. Therefore, the EMT process requires epithelial cells to lose their 
adhesive characteristics and acquire the ability to migrate (Thiery et al. 2009). This is important 
for palatogenesis because EMT disrupts the integrity of the MES, thus resulting in degradation of 
the MES for successful palatal fusion. 
The suppression of E-cadherin, one of the most common adhesion molecules, disrupts 
epithelial integrity and is thus the hallmark of EMT (Thiery et al. 2009). E-cadherin is mainly 
expressed in epithelial cells, including the palatal shelf MEE during development (Montenegro et 
al. 2000). Tgfβ is known to promote EMT by regulating proteins that inhibit E-cadherin 
expression, including Snail, Twist1, and Irf6 (Yu et al. 2008; Jalali et al. 2012; Ke et al. 2015). 
Studies carried out in mouse palates have shown that these proteins are closely related to each 
other. For example, Snail and Twist expressions are positively correlated with each other 
(Pungchanchaikul et al. 2005). In addition, Irf6 promotes the expression of Snail and it also 
affects epithelial adhesion stability during palatogenesis by forming a complex with E-cadherin 
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endocytosis regulators called Non-Metastatic Expressed (NME) proteins (Ke et al. 2015; Parada-
Sanchez et al. 2017). In summary, several molecular pathways work together to tightly control 
the EMT process during palatal fusion. 
1.3.2 TGFβ3 
Tgfβ3 is part of the Tgfβ superfamily of growth factors and it plays a key role in palatal 
development. The association between TGFβ3 mutation and cleft palate in both humans and 
animal studies further highlights the importance of this signaling molecule in palatogenesis 
(Proetzel et al. 1995; Carinci et al. 2007; Rienhoff et al. 2013). This is supported by the fact that 
mice with a Tgfβ3 knockout mutation presented with complete cleft palates but the phenotype 
could be rescued with in utero injections of viral vectors containing the Tgfβ3 gene into the 
amniotic sac (Wu et al. 2013). Tgfβ3 is specifically expressed at the MEE during palatal 
formation (Pelton et al. 1990). Its role during palatal fusion remains unclear but it has been 
implicated in multiple cellular processes including palatal adhesion, EMT, cell migration, and 
apoptosis (Proetzel et al. 1995; Martinez-Alvarez et al. 2000; Jalali et al. 2012).  
Prior to fusion, the opposing palatal shelves must adhere to each other after making 
contact to form the MES. Tgfβ3 promotes palatal shelf adhesion via filopodia and the regulation 
of cell-adhesion molecules such as chondroitin sulfate proteoglycan (CSPG) (Taya et al. 1999; 
Gato et al. 2002). This is supported by the observation that Tgfβ3-deficient mouse palatal shelves 
tended to slide off one another instead of adhering properly (Proetzel et al. 1995). On the other 
hand, some studies have suggested that Tgfβ3 promotes fusion through EMT instead of cell 
adhesion (Kaartinen et al. 1997; Jalali et al. 2012; Ke et al. 2015). Jalali et al. (2012) 
demonstrated that Tgfβ3 significantly downregulated the expression of E-cadherin during 
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palatogenesis and also increased cell migration of MES cells. The role Tgfβ3 plays during EMT 
has been highlighted in the previous section. Furthermore, there is evidence to suggest that Tgfβ3 
induces apoptosis during palatal fusion. Studies have shown that the absence of Tgfβ3 in mouse 
palates significantly reduced cell death in the MEE (Martinez-Alvarez et al. 2000; Dudas et al. 
2004). Some proposed that Irf6 acts as the mediator in the Tgfβ3 pathway to promote p21-
mediated cell death of the MEE (Iwata et al. 2013; Li et al. 2017). In conclusion, the importance 
of Tgfβ3 for palatal fusion is well-established and it may play multiple roles in this process. 
1.3.3 Twist1 
Twist1 protein is known to be a key regulator of EMT and is expressed within the MEE during 
palatogenesis (Yu et al. 2008; Kitase et al. 2011). It functions downstream of Tgfβ3 to promote 
Snail1 expression via the PI-3K signaling pathway within the palatal shelf epithelium (Yu et al. 
2008; Yu et al. 2013). The proposed mechanism for this is Twist1 recruits E-proteins to stimulate 
Snail1 promoter activity, which in turn inhibits E-cadherin expression during palatal fusion (Yu 
et al. 2013). Interestingly, a mutation of TWIST1 in humans results in Saethre-Chotzen 
syndrome, a disorder that features cleft palate as well (Gallagher et al. 1993). This further 
illustrates the significance of Twist1 during palatal development. 
1.3.4 β-catenin  
β-catenin protein is part of the canonical Wnt signaling pathway, whose role in palatal 
development has been heavily debated. There is evidence supporting the role of Wnt signaling in 
palatal shelf elevation, adhesion and fusion. Some studies have shown that the loss of Wnt 
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receptors Frizzled1 and Frizzled2 resulted in a failure of palatal shelf elevation (Yu et al. 2010). 
Others argue that since β-catenin is primarily detected in palatal epithelium, it likely functions as 
a cell adhesion molecule instead (Cobourne 2012). Conversely, there is also support for its role 
as a signaling mediator because both Tgfβ3 expression and apoptosis were found to be 
downregulated in the MEE of β-catenin-deficient mice (He et al. 2011). These mutant mice 
ultimately developed a cleft palate similar to Tgfβ3 knockout mice (He et al. 2011). These 
findings indicate that β-catenin is responsible for the regulation of Tgfβ3 in palatal shelf 
epithelium during embryogenesis. There is also a link between β-catenin and Twist, where β-
catenin promoted Twist expression while Twist downregulated β-catenin expression via a 
negative feedback loop (Yu et al. 2008). 
1.4 SYNDROMIC CLEFT LIP AND/OR PALATE 
Syndromic CL/P refers to the occurrence of CL/P when it is associated with other disorders such 
as Pierre Robin, Treacher Collins and Saethre-Chotzen syndrome (Gallagher et al. 1993; 
Venkatesh 2009). Other common features of these syndromes are hypoplastic midface, mandible 
and temporomandibular joint (TMJ) (Chang and Steinbacher 2012; Gangopadhyay et al. 2012). 
The skeletal abnormalities observed in these disorders indicate that the cellular mechanisms 
involved in skeletal development may involve similar molecular networks as syndromic CL/P 
pathogenesis. For example, the aforementioned Saethre-Chotzen syndrome is a result of a 
TWIST1 mutation, a gene that has been found to be essential for palatal fusion (Yu et al. 2008). 
In addition to cleft palate, patients with this syndrome also present with skeletal deformities such 
as craniosynostosis, facial asymmetry, short stature and brachydactyly (Gallagher et al. 1993). 
 9 
Therefore, it is possible that the proteins that play a vital role in palatal development, including 
Tgfβ3, β-catenin and Twist1, may also be important in the regulation of skeletal development. 
1.5 TRICHORHINOPHALANGEAL SYNDROME (TRPS) 
Cleft palate has been reported in rare cases of trichorhinophalangeal syndrome (TRPS) (Morioka 
et al. 1999; Solc et al. 2017). TRPS is an autosomal dominantly inherited disorder caused by 
TRPS1 gene mutations that result in haploinsufficiency of TRPS1, a zinc finger transcription 
factor that binds to DNA at GATA sequences (Momeni et al. 2000). Momeni et al. (2000) was 
the first to map the TRPS1 gene on chromosome 8q24. TRPS is categorized into 3 subtypes: 
TRPS I, TRPS II (also known as Langer-Giedion syndrome), and TRPS III. TRPS I is a 
consequence of a nonsense mutation within the TRPS1 gene that produces a truncated protein 
with a complete loss of function (Momeni et al. 2000). TRPS II is caused by a deletion of both 
the TRPS1 and EXT1 gene, which is located distal to the TRPS1 gene on chromosome 8q24 (Hall 
et al. 1974; Ludecke et al. 1995). Consequently, patients with TRPS II present with a 
combination of features from TRPS I and multiple exostoses as a result of the additional EXT1 
deficiency (Hall et al. 1974). Finally, TRPS III is considered to be a more severe version of 
TRPS I that is caused by missense mutations of the TRPS1 gene (Ludecke et al. 2001). 
Phenotypic evaluation of patients and their families revealed that parents of sporadic 
patients and other healthy relatives do not possess these mutations, which suggests a dominant 
nature of TRPS1 mutations (Ludecke et al. 2001). The characteristic clinical presentation of 
TRPS patients include sparse hair, bulbous nose, short stature, micrognathia, cone-shaped 
epiphyses of phalanges and dental abnormalities (Giedion 1966; Bennett et al. 1981; Ludecke et 
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al. 2001; Kantaputra et al. 2008). Some common oral features seen include microdontia, delayed 
tooth eruption, malocclusion, supernumerary teeth and high arched palate (Bennett et al. 1981; 
Kantaputra et al. 2008). While these 3 subtypes of TRPS have common clinical features, there is 
significant clinical variability between them. For example, most patients with TRPS I present 
with normal intelligence while TRPS II is usually associated with impaired mental development 
due to a greater mutation size (Brandt et al. 1997; Nardmann et al. 1997). However, mental 
retardation can also be seen in patients with TRPS I when there is a large chromosomal deletion 
(Hamers et al. 1990). It is likely that a minimum size of chromosomal deletion is required before 
mental retardation is observed (Bowen et al. 1985). The skeletal phenotypes are also highly 
variable between these categories. Compared to type I, patients with TRPS III have more severe 
brachydactyly and shorter stature (Ludecke et al. 2001). Patients with TPRS II are even shorter 
than those with type III because of the compounding effects of a deleted EXT1 gene, which also 
plays a role in skeletal development (Ludecke et al. 2001). Despite these differences however, 
the facial phenotype of patients in all subtypes of TRPS remain quite similar (Ludecke et al. 
2001). 
1.5.1 Role of Trps1 in embryogenesis 
The abnormalities observed in patients with TRPS suggest that the TRPS1 gene plays a major 
role during embryonic development. Studies using mouse embryos have shown that Trps1 is 
expressed in vital organs such as the brain, kidney and lungs (Kunath et al. 2002). Demonstration 
of pulmonary and renal defects in Trps1-deficient mice along with supporting case reports of 
TRPS patients experiencing respiratory and renal failure illustrate the importance of TRPS1 in 
organogenesis (Lu et al. 1997; Malik et al. 2002; Gai et al. 2009; Tasic et al. 2014).  Trps1 is also 
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necessary for proper development of hair follicles, tooth bud, cartilage, skeletal elements of long 
bones, facial bones, ribs and vertebrae (Kunath et al. 2002; Malik et al. 2002; Kantaputra et al. 
2008; Napierala et al. 2008). Skeletal staining experiments have supported the presence of 
thoracic defects in mice with a homozygous mutation of Trps1 (Trps1-/-) by showing that the 
mutant mice had delayed vertebral ossification, scoliosis and reduced thoracic volume (Malik et 
al. 2002).  
Within the craniofacial region, Trps1 is highly expressed in the first and second branchial 
arches during early embryogenesis (E11.5), which ultimately give rise to multiple craniofacial 
structures (Kunath et al. 2002; Kantaputra et al. 2008). Preliminary data from our lab also 
showed that in later stages of development (E12.5 - E13.5), Trps1  expression becomes localized 
to the subcutaneous nasal region, maxilla, mandible, and tongue (Figure 1.2A-B). When we 
examined Trps1 specifically in the secondary palate at E15.5, its expression was found to be 
confined to the lateral boundaries of the palatal shelves (Figure 1.2D). In summary, Trps1 is 
expressed in several regions during embryogenesis, including the oral cavity, and is essential for 
the development of various organs and skeletal elements. However, data regarding the specific 
role of Trps1 in craniofacial development remains limited. 
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Figure 1.2. Trps1 expression within craniofacial regions during embryogenesis. A,B) Sagittal view of a 
developing mouse embryo RNA in situ hybridization at E12.5 (A) illustrating Trps1 expression in subcutaneous 
snout region (arrowhead) and at E13.5 (B) showing Trps1 in the maxilla & mandible (dotted arrows), tongue and 
intervertebral disks. C,D) H&E staining (C) and RNA in situ hybridization (D) of E15.5 secondary palate in the 
transverse view demonstrating Trps1 expression within the lateral boundaries of the palate (solid arrows). 
(unpublished) 
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1.5.2 Cleft palate in Trps1 mutant mice 
TRPS has been studied extensively using mouse models because Trps1-deficient mice have 
craniofacial features that strongly resemble the phenotype of TRPS patients. Mice with a 
heterozygous Trps1 mutation (Trps1+/-) displayed subtle craniofacial defects such as abnormal 
palatal arch, shortened mandible and abnormal zygomatic arch (Malik et al. 2002). However, 
mice with a homozygous Trps1 mutation (Trps1-/-) had more severe malformations including 
cleft palate (Kantaputra et al. 2008) (Figure 1.3). This suggests that Trps1-deficiency has a dose-
dependent effect on the extent of the resultant craniofacial deformities.  
 
 
 
Figure 1.3. Cleft palate phenotype in Trps1-/- mice. H&E staining of coronal head sections of E18.5 mice showing 
A) wildtype (WT) mice underwent normal palatal development while B) Trps1-/- mice had cleft palates (*) Scale bar 
500μm. (unpublished) 
 
A deficiency in Trps1 has been shown to disturb palatal shelf fusion in previous 
experiments performed by our laboratory using cultured palatal shelves from Trps1-/- mice. After 
48 hours of ex vivo culture, fusion of all WT palatal shelves occurred (Figure 1.4A) but none of 
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the Trps1-/- palatal shelves initiated the fusion process (Figure 1.4B). Additionally, it appears that 
palatal adhesion may also be affected in Trps1-/- mice because expression of the cell adhesion 
mediator CSPG was lost on the epithelial surface of mutant palatal shelves and nasal septum 
(Figure 1.4C-F). Given that palatal shelf adhesion is a prerequisite for palatal fusion, this 
suggests that Trps1 may be involved in cellular processes even before to the fusion stage. We 
noticed that mesenchymal expression of CSPG was not affected in Trps1-/- mice, which indicates 
that Trps1-deficiency results in a cell type-specific loss of CSPG in the epithelium. Therefore, 
this specific loss of CSPG on palatal shelf epithelium surface is likely the reason that Trps1-/- 
mouse palates were unable to initiate fusion. 
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Figure 1.4. Trps1 is required for the initiation of the palatal shelves fusion and expression of CSPG on palatal 
and nasal septum surfaces. A,B) H&E staining of cultured palatal shelves from E13.5 WT (A) and Trps1-/- (B) 
mouse embryos. Fusion of palatal shelves was initiated in all WT palatal shelves (arrow, n=11) while Trps1-/- palatal 
shelves were unable to initiate fusion (arrowhead, n=11). C-F) Immunofluorescent staining for CSPG (red) on 
E14.5 WT (C,E) and Trps1-/- (D,F) mouse palatal shelves. CSPG typically present on the epithelial surface of WT 
palatal shelves and nasal septum (dotted arrows) were lost in Trps1-/- mice (arrowheads), while mesenchymal 
expression remained unaffected (block arrows). Scale bar 50µm. NS- nasal septum, PS- palatal shelf, T- tongue. 
(unpublished) 
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2.0  OBJECTIVE OF STUDY 
Although the phenotype of TRPS patients clearly indicates that TRPS1 is involved in skeletal and 
craniofacial development, the specific role of TRPS1 in these processes is not well understood. 
The objectives of this study are: 1) to characterize the craniofacial and skeletal phenotype of 
Trps1-/- mice; 2) to define the expression pattern of Trps1 during palatogenesis; and 3) to identify 
dysregulated protein expressions during palatal fusion caused by a Trps1-deficiency. Our 
hypothesis is that a deficiency in Trps1 will result in craniofacial skeletal defects, including cleft 
palate, and downregulate the expression of proteins essential for palatal fusion. 
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3.0  MATERIAL AND METHODS 
3.1 MOUSE MODEL 
Trps1-/- mice were generated previously by excision of the exon coding for the DNA binding 
domain of the TRPS1 protein (Malik et al. 2002). These mice were maintained on 129svev and 
C57BL/6J backgrounds. All animal work performed were approved by IACUC.  
3.2 WHOLE MOUNT SKELETAL STAINING 
For timed matings, the day the plug was observed was designated E0.5. At day E18.5, pregnant 
mice were sacrificed in an isoflurane chamber following proper euthanasia guidelines. E18.5 
C57BL/6J wildtype (WT) (n=5) and Trps1-/- (n=4) mice pups were collected. Following 
complete removal of skin and excess soft tissues, the embryos were fixed in 95% ethanol 
overnight. The samples were stained with 0.03% Alcian blue (Sigma-Aldrich, A3157) solution 
overnight, washed with 95% ethanol for 3h, and cleared with 2% KOH for 12h. The embryos 
were then stained with 0.01% Alizarin red (Sigma- Aldrich, A5533) solution overnight and 
cleared in 1% KOH/20% glycerol for 48h. Specimens were stored and imaged in 1:1 
glycerol/95% ethanol solution. Leica M165FC microscope and Leica Application Suite software 
was used for imaging. 
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3.3 HEMATOXYLIN & EOSIN (H&E) STAINING 
7µm thick sections of paraffin-embedded 129svev mouse heads were deparaffinized with xylene 
and rehydrated. The tissues were stained with Harris Hematoxylin solution (Thermo Fisher 
Scientific) and counterstained with Eosin Y solution (Thermo Fisher Scientific). The stained 
tissues were then dehydrated serially with ethanol and placed in xylene. The samples were 
mounted in mounting medium (Richard-Allan Scientific). 
3.4 FLUORESCENT IMMUNOHISTOCHEMISTRY 
Paraffin-embedded tissue samples from C57BL/6J WT and Trps1-/- mouse heads fixed in either 
4% paraformaldehyde (for detection of Trps1 and Tgfβ3) or Carnoy’s solution (for detection of 
CSPG, β-catenin and Twist1) were obtained from our laboratory’s previous work. Heat-induced 
epitope retrieval was performed in sodium citrate buffer (10 mM sodium citrate, 0.05% 
Tween20, pH=6.5,). The tissues were blocked with 10% bovine serum albumin (BSA) in 1xPBS 
and incubated with primary antibody at 4oC overnight. The primary antibodies used were 1:50 
rabbit anti-TRPS1 (Abnova, PAB17465), 1:200 anti-chondroitin sulfate proteoglycan (Sigma, 
C8035), 1:100 rabbit anti-TGFβ3 (Abcam, ab15537), 1:250 rabbit anti-β-catenin (Abcam, 
ab50581), and 1:100 rabbit anti-Twist1 (Abcam, ab32572). After rinsing, a secondary antibody 
conjugated with anti-rabbit AlexaFluor 488 (Thermo Fisher Scientific) was used for detection 
and incubated at room temperature for 30 minutes. The stained tissues were mounted in 
Molecular Probes ProLong Gold Antifade Mountant with DAPI (Thermo Fisher Scientific). The 
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slides were stored at 4oC and images were taken with Zeiss AxioCam on a Zeiss Axioskop A1 
microscope and ZEN software. 
3.5 CRANIOFACIAL MEASUREMENTS OF WHOLE MOUNT STAINING 
SAMPLES 
Total head length was measured from the tip of nasal cartilage to the most posterior aspect of the 
supraoccipital bone. The nasal length was measured from the tip of nasal cartilage to the 
frontonasal suture. The nasal angle was determined from the images by drawing a plane from the 
tip of the nasal cartilage to the superior border of supraoccipital bone and a second plane tangent 
to the nasal bone surface. The angle was then measured between the two planes using a 
protractor. Mandible length was measured from the most posterior point at the condylar process 
to the most anterior point at the symphysis. Lengths of the head, nose and mandible were 
measured with calipers. 
3.6 STATISTICAL ANALYSIS 
Non-parametric Wilcoxon rank sum test was used to determine a difference between WT and 
Trps1-/- mice head, nose and mandible measurements with α=0.05. The statistical analysis was 
performed using StataSE software. 
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4.0  RESULTS 
4.1 SKELETAL AND CRANIOFACIAL PHENOTYPE OF TRPS1-/- MICE 
TRPS1 haploinsufficiency in humans results in characteristic features that indicate a disturbance 
in skeletal development. The severity of skeletal deformation in mice with a homozygous Trps1 
mutation is further increased, specifically within the thoracic spine and ribs, which ultimately 
leads to neonatal respiratory failure and death (Malik et al. 2002). For this reason, analysis of the 
Trps1-/- mouse skeletal elements in this study was performed on E18.5 embryos shortly before 
birth. Comparisons of whole mount skeletal preparations of E18.5 WT and Trps1-/- mice 
demonstrated apparent bowing of the forelimb long bones, specifically the ulna and radius, and 
an overall underdevelopment of the sternum in Trps1-/- mice (Figure 4.1A,B). Closer inspection 
of the Trps1-/- mouse sternums revealed that the ossification of the xiphoid process was 
especially reduced compared to the WT group (Figure 4.1C,D). Analysis of the thoracic region 
showed delayed ossification of the cervical vertebrae and abnormal shape of the rib cage in 
Trps1-/- mice (Figure 4.1A,B; E,F).  
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Figure 4.1. Appendicular and axial skeleton abnormalities in Trps1-/- mice. Alcian blue (cartilage) and Alizarin 
red (ossified bone) staining of E18.5 WT (left) and Trps1-/- (right) mouse skeletons. A,B) Side view of the embryo 
demonstrating increased bowing of ulna and radius, and underdevelopment of the sternum (arrows) in Trps1-/- mice. 
C,D) Magnified view of the sternum illustrating reduced ossification especially at the xiphoid process in Trps1-/- 
mice (arrowheads). E,F) Frontal view of the thoracic vertebrae and ribs showing delayed vertebral ossification in 
Trps1-/- mice. Scale bar 2mm. 
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The skeletal analysis was then focused on the craniofacial region. No statistically 
significant difference was found between the mean head length of Trps1-/- mice (9.4mm ± 
0.3mm) and WT mice (9.9mm ± 0.4mm) (Figure 4.2/4.3, Table A1). However, the mean nasal 
length of Trps1-/- mice (2.1mm ± 0.1mm) was 15% shorter than the WT mice (2.5mm ± 0.1mm) 
(p<0.05) (Figure 4.2/4.3, Table A1). The nasal angle of the Trps1-/- mice (31.1o ± 1o) was on 
average 18% steeper than the WT mice (26.4 o ± 2.8o) (p<0.05) (Figure 4.2/4.3, Table A1). No 
apparent differences in the nasal cartilage were detected. 
Multiple differences between WT and Trps1-/- mandibles were also detected. The Trps1-/- 
mutant phenotype includes unerupted incisors, reduced mineralized regions as well as less 
cartilage in the coronoid, condylar and angular processes (Figure 4.2B). We also found that the 
average Trps1-/- mandible (4.6mm ± 0.1mm) was 17% shorter than the average WT mandible 
(5.6mm ± 0.1mm) (p<0.05) (Figure 4.2/4.3, Table A1). Meckel’s cartilage and clearly 
demarcated molar crypts were present in both genotypes (Figure 4.2B). In the midface region, 
the zygomatic arches were less developed in Trps1-/- mice in comparison with the WT littermates 
(Figure 4.4A,B), which is consistent with the craniofacial skeletal phenotype of adult Trps1+/- 
mice (Malik et al. 2002). Additionally, analysis of the skeletal preparations revealed 
underdeveloped vomer bones in Trps1-/- mice (Figure 4.4C,D). Finally, we observed cranial base 
abnormalities in Trps1-/- mice, where the basisphenoid was smaller and the presphenoid bone 
was absent (Figure 4.4E-H). However, there was no difference in the basioccipital and cranial 
vault bones between the two genotypes (Figure 4.4E-J). These results suggest that Trps1 plays a 
vital role in the development of many thoracic, appendicular and craniofacial skeletal elements.  
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Figure 4.2. Craniofacial abnormalities in Trps1-/- mice. Alcian blue (cartilage) and Alizarin red (ossified bone) 
staining of E18.5 WT and Trps1-/- mouse heads. A) Landmarks for head and nasal length (top), nasal angle (middle) 
and mandibular length (bottom). B) Side view of the head skull (top) and mandible (middle); top view of mandible 
(bottom): Coronoid process, condylar process/cartilage, and angular process/cartilage of Trps1-/- mice were 
hypoplastic (dotted arrows). The mandibular incisors have not erupted in Trps1-/- mandible (block arrow). Meckel’s 
cartilage and molar crypts were clearly visualized in both WT and knockout phenotypes. Scale bar 2mm. ag- 
angular process, cr- coronoid process, cd- condylar process, fr- frontal bone, in- incisor, mc- Meckel’s cartilage, 
mlc- molar crypt, n- nasal bone, nc- nasal cartilage, so- supraoccipital. 
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Figure 4.3. Comparative quantitative analysis of WT and Trps1-/- mice craniofacial dimensions. There was no 
significant difference in total length of the head between the two groups but the nose was significantly shorter and 
downward-sloping in the Trps1-/- mice. The Trps1-/- mandible was also significantly shorter than WT. Red dashes 
represent the mean value in each data set.  Solid data points represent individual samples, data points with white 
circle within indicate 2 samples with the same measurement and data points with white cross within indicate 3 
samples with the same measurement. Error bars indicate the standard deviation of the sample. * indicates 
statistically significant differences between the WT and Trps1-/- groups (p<0.05). 
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Figure 4.4. Midface and cranial base abnormalities in Trps1-/- mice. Alcian blue (cartilage) and Alizarin red 
(ossified bone) staining of E18.5 WT (left) and Trps1-/- (right) mouse heads. A,B) Inferior view of skull 
demonstrating hypoplastic  zygomatic process (solid arrows) and palatal shelf separation (boxed area) in Trps1-/- 
mice. C,D) Magnified view of the nasal area illustrating underdeveloped vomer bones in Trps1-/- mice (block 
arrows). E,F) The basioccipital bone is unaffected in Trps1-/- mice, while the basisphenoid bone is smaller and the 
cleft palate is evident with the unfused palatal shelves. G,H) Removal of palatine bones revealed the absence of 
presphenoid bone in Trps1-/- mice (dotted arrow). I,J) Cranial vault bones showed no apparent differences between 
the two groups. Scale bar: 2mm. bo- basioccipital, bs- basisphenoid, p- palatine bone, ps- presphenoid. 
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4.2 EXPRESSION OF TRPS1 IN WILDTYPE MOUSE PALATAL SHELVES 
Due to the clear presence of cleft palate in Trps1 mutant mice as demonstrated by the skeletal 
staining experiments, our next objective was to investigate how Trps1 might affect palatal 
development by delineating its expression using immunohistochemistry. Previous studies have 
shown that Trps1 has a wide range of expression during mouse embryogenesis and is strongly 
expressed in the subcutaneous region of the snout, maxilla and mandible (Kunath et al. 2002). 
Here, we focused our study on the expression of Trps1 during different stages of palatogenesis. 
We found that Trps1 was generally expressed in the mesenchyme of the nasal septum and 
maxillary process, developing intrinsic muscles of the tongue, and in the tips of the palatal 
shelves. During palatal outgrowth (E12.5), Trps1 protein was detected in the nasal region of the 
maxillary process (Figure 4.5). Trps1 was also found in palatal shelf mesenchyme and 
epithelium, including the epithelium surrounding the palatal shelves at the future fusion sites 
(Figure 4.5C). As development progressed (E13.5), the presence of Trps1 became more 
widespread in the palatal shelves, mandible and tongue, especially in the posterior region of the 
oral cavity (Figure 4.6C,D). When the palatal shelves were in the adhesion/fusion stage (E14.5), 
Trps1 was still expressed in the nasal septum, maxillary mesenchyme, palatal shelf epithelium 
and tongue (Figure 4.7). Trps1 expression was evident in the seam of the MEE in both anterior 
and posterior sections of the palate (Figure 4.7E,F), suggesting that Trps1 may play a role in 
palatal fusion. 
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Figure 4.5. Trps1 protein expression pattern during mouse palatal development at E12.5. A) H&E staining of a 
WT frontal head section of the oral cavity at E12.5. B) Immunofluorescent staining for Trps1 protein (green) 
showing that Trps1 was expressed in a skeletogenic condensation region (dotted arrow) and the nasal region of the 
maxillary process (arrow). C) Trps1 was detected in the MEE of the palatal shelf (arrowhead). D) Magnified view of 
the boxed area in B showing Trps1 expression in a localized mesenchymal area within the nasal region of the 
maxillary process (arrow) and the adjacent epithelium. Scale bar 50µm. PS- palatal shelf, T- tongue. 
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Figure 4.6. Trps1 protein expression pattern during mouse palatal development at E13.5. A) H&E staining of a 
WT frontal head sections of the oral cavity at E13.5. B) Immunofluorescent staining for Trps1 protein (green) 
showing Trps1 expression in maxillary process mesenchyme (arrows) and developing muscles of the tongue (T). C) 
Anterior section of the oral cavity showing Trps1 expression in the palatal shelf, maxillary mesenchyme (arrow) and 
tongue (T). D) Posterior section of the oral cavity showing Trps1 in maxillary mesenchyme (arrow), palatal shelf 
epithelium (arrowhead) and tongue (T). Scale bar 50µm. MN- mandible, NS- nasal septum, PS- palatal shelf, T- 
tongue. 
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Figure 4.7. Trps1 protein expression pattern during mouse palatal development at E14.5. A) H&E staining of a 
WT frontal head sections of the oral cavity at E14.5. B) Immunofluorescent staining for Trps1 protein (green) 
showing Trps1 within the nasal septum (NS), palatal shelf epithelium (arrowhead), maxillary mesenchyme (arrows) 
and tongue (T). C,D) Higher magnification of anterior (C) and posterior (D) palatal shelf sections illustrating Trps1 
presence in the maxillary mesenchyme laterally (arrow) and palatal shelf epithelium (arrowhead). E,F) Increased 
magnification of the anterior (E) and posterior (F) sections where the palatal shelves meet demonstrating clear Trps1 
expression at the MEE (arrowheads). Scale bar 50µm. MX- maxilla, NS- nasal septum, PS- palatal shelf, T- tongue. 
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4.3 DOWNREGULATION OF TGFβ3, β-CATENIN AND TWIST1 EXPRESSION IN 
TRPS1-/- PALATES 
The association between TGFβ3 mutation and cleft palate in both humans and animal studies 
highlights the importance of this signaling molecule in palatogenesis (Proetzel et al. 1995; 
Carinci et al. 2007; Rienhoff et al. 2013). Given that epithelial expression of the cell adhesion 
molecule CSPG is lost in Trps1-/- palatal shelves (unpublished data) and that accumulation of 
CSPG at the fusion surfaces depends on Tgfβ3 (Gato et al. 2002; Krauss 2011), we hypothesized 
that the observed absence of CSPG is related to a disruption in Tgfβ3 signaling. 
Immunohistochemical staining revealed that Tgfβ3 follows a very similar expression pattern to 
Trps1 in WT mice where they are both strongly expressed in the maxillary mesenchyme and 
palatal shelf MEE (Figure 4.8). However, like CSPG, Tgfβ3 expression was lost in the MEE of 
Trps1 knockout palatal shelves (Figure 4.9). This suggests that CSPG deficiency on the fusion 
surface is a consequence of the loss of Tgfβ3 expression in Trps1-/- palatal shelf epithelium. 
The absence of Tgfβ3 in the Trps1-/- epithelium led us to investigate other proteins within 
the palatal shelf epithelium that are essential for palatal fusion and may be involved in Trps1 
regulatory networks. We analyzed Twist1, which is the key EMT regulator required for palatal 
fusion and functions downstream of Tgfβ3, and β-catenin, which has been implicated in both 
Trps1 and Tgfβ3 signaling (Yu et al. 2008; He et al. 2011; Fantauzzo and Christiano 2012). We 
discovered that both Twist1 and β-catenin proteins were primarily present in the epithelium of 
the WT E14.5 palatal shelves, but their expressions were undetectable in Trps1-/- palatal shelves 
(Figure 4.9). Therefore, it seems that Trps1 is required for the epithelial expression of several 
proteins critical for palatal shelf fusion.  
 31 
 
Figure 4.8. Similarities between the expression patterns of Trps1 and Tgfβ3. Both Trps1 (left) and Tgfβ3 (right) 
are expressed in maxillary mesenchyme (arrows) and palatal shelf epithelium (arrowheads). Scale bar 50µm. NS- 
nasal septum, PS- palatal shelf. 
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Figure 4.9. Expression of Tgfβ3, β-catenin and Twist1 were decreased in Trps1-/- mouse palatal shelf 
epithelium. Immunofluorescent staining for Tgfβ3, β-catenin and Twist1 (green) were performed on E14.5 WT and 
Trps1-/- mice and imaged within the boxed area marked on the H&E images. Anterior (A) and posterior (B) sections 
of palatal shelves demonstrated positive Tgfβ3, β-catenin and Twist1 signal in the MEE of WT mice (arrows) but 
not in Trps1-/- palatal shelf epithelium (arrowheads). Scale bar: 50µm. MN- mandible, NS- nasal septum, PS- palatal 
shelf, T- tongue. 
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5.0  DISCUSSION 
TRPS1 is crucial for proper skeletal and craniofacial development, as evident by the 
characteristic phenotype of TRPS patients. This is supported by other studies that have 
demonstrated that Trps1 is expressed in the precursor cells of long bones, ribs, vertebrae and 
facial bones (Kunath et al. 2002). The skeletal phenotype of Trps1-/- mice seen in this study is 
similar to what Malik et al. (2002) and Suemoto et al. (2007)  described in regards to the 
abnormal ribcage anatomy and underdeveloped forelimbs, sternum and vertebrae. Here, we also 
noted that the shape of the forelimb long bones displayed a bowed appearance compared to the 
WT mice. Interestingly, the thoracic defects observed in Trps1-/- mice are analogous to the 
phenotype of TRPS patients who display pectus carinatum, a chest deformity featuring a 
protrusive sternum due to abnormal costal cartilage growth (Beals 1973; Felman and Frias 1977). 
Therefore, it appears that Trps1 is highly involved in endochondral bone formation within both 
the appendicular and axial skeleton.  
Disruption in endochondral bone development within the craniofacial region of TRPS 
patients has also been described before. Cephalometric studies performed by King and Frias 
(1979) revealed a shortening of the posterior cranial base in TRPS patients. In this study of mice 
with Trps1-/- mutation, we detected abnormalities within the anterior cranial base instead, most 
notably the complete absence of the presphenoid bone in E18.5 Trps1-/- mice. Other craniofacial 
abnormalities of Trps1-/- mice identified here include a short and downward sloping nose, 
 34 
hypoplastic zygomatic process of the maxilla, and micrognathic mandible with underdeveloped 
bony processes. These features are consistent with the phenotype of adult Trps1+/- mice (Malik et 
al. 2002) and also draws resemblance to the bulbous nose and hypoplastic jaws typically seen in 
TRPS patients (Ludecke et al. 2001; Griffiths et al. 2016). Further examination of the mandible 
also revealed a reduction in the cartilage component of the condylar and angular processes in 
Trps1-/- mice. This is consistent with previous studies identifying Trps1 as a regulator of 
chondrocyte proliferation and differentiation in appendicular skeleton and TMJ (Suemoto et al. 
2007; Napierala et al. 2008; Wuelling et al. 2009; Michikami et al. 2012). It has been proposed 
that the condylar hypoplasia seen in Trps1 mutant mice may be due to cellular disruption of the 
condylar chondrocytes resulting in premature chondrocyte maturation and decreased 
proliferation (Michikami et al. 2012). In terms of dental abnormalities, we noted delayed tooth 
eruption in E18.5 Trps1-/- mice, a feature that is also common in TRPS patients. Finally, we also 
detected the presence of cleft palate in Trps1-/- mice (Figure 4.4F), which has been previously 
reported by Kantaputra et al. (2008). Despite the dysplastic cranial base and jaws in Trps1 
mutant mice, it appears that the cranial vault was largely unaffected. The craniofacial 
characteristics of Trps1 homozygous mutant mice are highly comparable to the phenotype of 
patients with TRPS1 haploinsufficiency but with increased severity, indicating the dose-
dependent effect of Trps1-deficiency. 
To investigate the role of Trps1 during palatal development, we delineated its expression 
pattern at various embryonic stages. To review, the key steps of palatogenesis are initiation of 
palatal outgrowth from the maxillary process, vertical growth, palatal shelf elevation, horizontal 
growth, adhesion and fusion. Interference at any of these stages can result in cleft palate. We 
demonstrated that Trps1 is expressed in the oral cavity during palatal development, specifically 
 35 
in the mesenchyme of the maxilla, mandible, tongue and nasal septum. This suggests that a 
mutation in the Trps1 gene may affect palatogenesis at various stages, but the specific 
mechanism remains unknown. For example, the presence of Trps1 in palatal shelf mesenchyme 
opens up the possibility of Trps1 playing a role in palatal shelf elevation as this process is 
thought to be guided by internal forces (Li et al. 2017). This possibility is supported by the fact 
that by E14.5, WT palatal shelves have elevated above the tongue while the Trps1-/- palatal 
shelves were still oriented vertically (Figure 4.9). The expression of Trps1 in the developing 
intrinsic muscles of the tongue suggests that it could also play a role in tongue descent (Figure 
4.6). In other craniofacial disorders such as Pierre Robin sequence, cleft palate results from 
obstructed tongue descent secondary to a micrognathic mandible (Levi et al. 2011). Thus, the 
small mandible of Trps1-/- mice could also be a contributing factor to the tongue’s inability to 
descend. Finally, the clear expression of Trps1 within the palatal shelf epithelium suggested that 
cleft palate in Trps1-/- mice is due to a failure of palatal shelf fusion. This was confirmed by our 
laboratory’s unpublished data showing that Trps1-/- palatal shelves were not able to initiate the 
fusion process, which is most likely caused by a failure in palatal shelf adhesion secondary to the 
loss of CSPG on the epithelial surface (Figure 1.4). Our finding that Tgfβ3 was absent in Trps1-/- 
palatal epithelium strongly suggests that this CSPG-deficiency is a consequence of the loss of 
Tgfβ3. In summary, Trps1 is required for the initiation of palatal shelf fusion and for the 
epithelial expression of several other proteins critical for this process. 
Trps1 has been shown to interact with the Tgfβ and canonical Wnt signaling pathways in 
kidney and hair follicles, respectively (Gai et al. 2009; Fantauzzo and Christiano 2012). 
However, the mechanism by which a Trps1-deficiency decreases the expression of Tgfβ3, β-
catenin and Twist1 in the MEE remains elusive. Most studies have shown that Trps1 primarily 
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functions by inhibiting expression of its target genes (Malik et al. 2001; Napierala et al. 2008). 
However, some evidence shows that Trps1 can also act as a transcriptional activator in hair 
follicle progenitors (Fantauzzo and Christiano 2012). This opens up the possibility that 
expression of Tgfβ3, β-catenin or Twist1 might be directly activated by Trps1 in palatal shelf 
epithelium (Figure 5.1). 
 
Figure 5.1. Proposed mechanism by which Trps1 regulates Tgfβ3, β-catenin and Twist1 expression during 
palatal fusion. The direct relationship between Trps1 and β-catenin in palatal shelves is unclear. 
The regulation of palatogenesis requires elaborated communication between different 
signaling molecules including Tgfβ3, β-catenin and Twist1. As illustrated in Figure 5.1, β-
catenin is necessary for Tgfβ3 expression in palatal shelf epithelium, which in turn promotes 
Twist1 expression (Yu et al. 2008; He et al. 2011). Both Tgfβ3 and Twist1 are essential for 
palatal fusion due to their role in EMT stimulation (Yu et al. 2009; Ke et al. 2015). Interestingly, 
Trps1 has instead been associated with the reverse process of EMT, known as MET, in tumor 
and liver cells and positively correlated with E-cadherin levels (Su et al. 2014; Zhe et al. 2015; 
Huang et al. 2016). Some proposed mechanisms include Trps1 downregulating the expression of 
the EMT promoting protein Zeb2 and Trps1 directly activating the expression of an EMT 
antagonist Foxa1 (Stinson et al. 2011; Huang et al. 2016). On the other hand, Twist1 is able to 
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silence Foxa1 expression in cancer cells to promote EMT (Xu et al. 2016). These pathways are 
summarized in Figure 5.2. While these data from malignant tissues support the role of Trps1 in 
MET, the developmental functions of Trps1 may also stem from its regulation of other genes 
such as Tgfβ3, β-catenin and Twist1 to promote cell adhesion or EMT in palatal shelves (Figure 
5.1).  
 
Figure 5.2. Relationship between Trps1 and EMT found in cancer cell studies. 
 
Our study highlights the importance of Trps1 in skeletal and craniofacial development, 
especially palatal fusion. However, further studies should be carried out to investigate whether 
exogenous Tgfβ3, β-catenin or Twist1 can rescue the cleft palate phenotype of a Trps1-
deficiency and to examine other proteins in related pathways that may be dysregulated as well. 
This would allow us to advance our understanding of the molecular mechanisms underlying the 
cleft palate pathogenesis in TRPS. Here, we have examined the processes of palatal shelf 
adhesion and fusion but future studies should also delve into how Trps1 may affect other stages 
of palatogenesis, including tongue descent, palatal shelf proliferation, elevation, apoptosis or 
EMT. 
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6.0  CONCLUSIONS 
In summary, Trps1 is required for proper axial, appendicular and craniofacial skeleton, including 
the anterior cranial base and jaws. During development, Trps1 is expressed in the epithelium and 
mesenchyme of the palatal shelves and is necessary for the initiation of palatal fusion. 
Additionally, the expressions of other proteins essential for palatal fusion, such as Tgfβ3, β-
catenin and Twist1, are dependent on Trps1. 
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APPENDIX 
CRANIOFACIAL DIMENSIONS FROM WHOLE MOUNT SKELETAL STAINING 
Table A1. Comparison of craniofacial measurements between wildtype (WT) and Trps1-/- mice.  * indicates a 
statistical significant difference between the two groups. 
 Head length 
(mm) 
Snout length 
(mm) 
Snout angle (o)  Mandible length 
(mm)  
WT 1 10.1 2.5 31 5.5 
WT 2 10 2.4 25 5.5 
WT 3 9.9 2.6 27 5.75 
WT 4 9.2 2.5 24 5.5 
WT 5 10.2 2.4 25 5.6 
Trps1-/- 1 9.3 2.1 30 4.7 
Trps1-/- 2 9.8 2 31 4.6 
Trps1-/- 3 9.3 2 32.5 4.8 
Trps1-/- 4 9 2.3 31 4.4 
Average WT 9.88 ± 0.35 2.48 ± 0.07 26.4 ± 2.79 5.57 ± 0.10 
Average Trps1-/-  9.35 ± 0.29 2.1 ± 0.12 31.13 ± 1.03 4.63 ± 0.15 
% difference 5% 15% 18% 17% 
p-value 0.08 0.01* 0.04* 0.01* 
 40 
BIBLIOGRAPHY 
American Cleft Palate-Craniofacial Association. 1993. Parameters for evaluation and treatment 
of patients with cleft lip/palate or other craniofacial anomalies. American cleft palate-
craniofacial association. Cleft Palate Craniofac J. 30 Suppl:S1-16. 
Baek JA, Lan Y, Liu H, Maltby KM, Mishina Y, Jiang R. 2011. Bmpr1a signaling plays critical 
roles in palatal shelf growth and palatal bone formation. Developmental biology. 
350(2):520-531. 
Beals RK. 1973. Tricho-rhino-phalangeal dysplasia. Report of a kindred. J Bone Joint Surg Am. 
55(4):821-826. 
Bennett CG, Hill CJ, Frias JL. 1981. Facial and oral findings in trichorhinophalangeal syndrome 
type 1 (characteristics of trps 1). Pediatr Dent. 3(4):348-352. 
Bowen P, Biederman B, Hoo JJ. 1985. The critical segment for the langer-giedion syndrome: 
8q24.11----q24.12. Ann Genet. 28(4):224-227. 
Brandt CA, Ludecke HJ, Hindkjaer J, Stromkjaer H, Pinkel D, Herlin T, Bolund L, Friedrich U. 
1997. A de nevo complex t(7;13;8) translocation with a deletion in the trps gene region. 
Hum Genet. 100(3-4):334-338. 
Bush JO, Jiang R. 2012. Palatogenesis: Morphogenetic and molecular mechanisms of secondary 
palate development. Development (Cambridge, England). 139(2):231-243. 
Carinci F, Scapoli L, Palmieri A, Zollino I, Pezzetti F. 2007. Human genetic factors in 
nonsyndromic cleft lip and palate: An update. Int J Pediatr Otorhinolaryngol. 
71(10):1509-1519. 
Chang CC, Steinbacher DM. 2012. Treacher collins syndrome. Semin Plast Surg. 26(2):83-90. 
Cobourne MT. 2012. Cleft lip and palate: Epidemiology, aetiology, and treatment. Karger. 
Dixon MJ, Marazita ML, Beaty TH, Murray JC. 2011. Cleft lip and palate: Understanding 
genetic and environmental influences. Nat Rev Genet. 12(3):167-178. 
Dudas M, Nagy A, Laping NJ, Moustakas A, Kaartinen V. 2004. Tgf-β3-induced palatal fusion 
is mediated by alk-5/smad pathway. Developmental biology. 266(1):96-108. 
Fantauzzo KA, Christiano AM. 2012. Trps1 activates a network of secreted wnt inhibitors and 
transcription factors crucial to vibrissa follicle morphogenesis. Development. 139(1):203-
214. 
Felman AH, Frias JL. 1977. The trichorhinophalangeal syndrome: Study of 16 patients in one 
family. American Journal of Roentgenology. 129(4):631-638. 
Gai Z, Zhou G, Itoh S, Morimoto Y, Tanishima H, Hatamura I, Uetani K, Ito M, Muragaki Y. 
2009. Trps1 functions downstream of bmp7 in kidney development. J Am Soc Nephrol. 
20(11):2403-2411. 
 41 
Gallagher ER, Ratisoontorn C, Cunningham ML. 1993. Saethre-chotzen syndrome. In: Adam 
MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, 
Amemiya A, Ledbetter N, editors. Genereviews((r)). Seattle (WA). 
Gangopadhyay N, Mendonca DA, Woo AS. 2012. Pierre robin sequence. Semin Plast Surg. 
26(2):76-82. 
Gato A, Martinez ML, Tudela C, Alonso I, Moro JA, Formoso MA, Ferguson MW, Martinez-
Alvarez C. 2002. Tgf-beta(3)-induced chondroitin sulphate proteoglycan mediates palatal 
shelf adhesion. Developmental biology. 250(2):393-405. 
Giedion A. 1966. [tricho-rhino-phalangeal syndrome]. Helv Paediatr Acta. 21(5):475-485. 
Gimbel M, Ashley RK, Sisodia M, Gabbay JS, Wasson KL, Heller J, Wilson L, Kawamoto HK, 
Bradley JP. 2007. Repair of alveolar cleft defects: Reduced morbidity with bone marrow 
stem cells in a resorbable matrix. The Journal of craniofacial surgery. 18(4):895-901. 
Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. 2016. Rook's textbook of dermatology. 
Wiley. 
Hall BD, Langer LO, Giedion A, Smith DW, Cohen MM, Jr., Beals RK, Brandner M. 1974. 
Langer-giedion syndrome. Birth Defects Orig Artic Ser. 10(12):147-164. 
Hamers A, Jongbloet P, Peeters G, Fryns JP, Geraedts J. 1990. Severe mental retardation in a 
patient with tricho-rhino-phalangeal syndrome type i and 8q deletion. European journal 
of pediatrics. 149(9):618-620. 
He F, Xiong W, Wang Y, Li L, Liu C, Yamagami T, Taketo MM, Zhou C, Chen Y. 2011. 
Epithelial wnt/beta-catenin signaling regulates palatal shelf fusion through regulation of 
tgfbeta3 expression. Developmental biology. 350(2):511-519. 
Huang JZ, Chen M, Zeng M, Xu SH, Zou FY, Chen D, Yan GR. 2016. Down-regulation of trps1 
stimulates epithelial-mesenchymal transition and metastasis through repression of foxa1. 
J Pathol. 239(2):186-196. 
Iwata J, Suzuki A, Pelikan RC, Ho TV, Sanchez-Lara PA, Urata M, Dixon MJ, Chai Y. 2013. 
Smad4-irf6 genetic interaction and tgfbeta-mediated irf6 signaling cascade are crucial for 
palatal fusion in mice. Development (Cambridge, England). 140(6):1220-1230. 
Jalali A, Zhu X, Liu C, Nawshad A. 2012. Induction of palate epithelial mesenchymal transition 
by transforming growth factor beta3 signaling. Dev Growth Differ. 54(6):633-648. 
Jia S, Zhou J, Fanelli C, Wee Y, Bonds J, Schneider P, Mues G, D'Souza RN. 2017. Small-
molecule wnt agonists correct cleft palates in pax9 mutant mice in utero. Development 
(Cambridge, England). 144(20):3819-3828. 
Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF. 1997. Transforming growth factor-
beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and 
associated degradation of the basement membrane. Dev Dyn. 209(3):255-260. 
Kantaputra P, Miletich I, Ludecke HJ, Suzuki EY, Praphanphoj V, Shivdasani R, Wuelling M, 
Vortkamp A, Napierala D, Sharpe PT. 2008. Tricho-rhino-phalangeal syndrome with 
supernumerary teeth. J Dent Res. 87(11):1027-1031. 
Ke CY, Xiao WL, Chen CM, Lo LJ, Wong FH. 2015. Irf6 is the mediator of tgfbeta3 during 
regulation of the epithelial mesenchymal transition and palatal fusion. Sci Rep. 5:12791. 
King GJ, Frias JL. 1979. A cephalometric study of the craniofacial skeleton in 
trichorhinophalangeal syndrome. American journal of orthodontics. 75(1):70-77. 
Kitase Y, Yamashiro K, Fu K, Richman JM, Shuler CF. 2011. Spatiotemporal localization of 
periostin and its potential role in epithelial-mesenchymal transition during palatal fusion. 
Cells Tissues Organs. 193(1-2):53-63. 
 42 
Krauss R. 2011. Mouse models of developmental genetic disease. Elsevier Science. 
Kunath M, Ludecke HJ, Vortkamp A. 2002. Expression of trps1 during mouse embryonic 
development. Mech Dev. 119 Suppl 1:S117-120. 
Lan Y, Jiang R. 2009. Sonic hedgehog signaling regulates reciprocal epithelial-mesenchymal 
interactions controlling palatal outgrowth. Development (Cambridge, England). 
136(8):1387-1396. 
Levi B, Brugman S, Wong VW, Grova M, Longaker MT, Wan DC. 2011. Palatogenesis: 
Engineering, pathways and pathologies. Organogenesis. 7(4):242-254. 
Li C, Lan Y, Jiang R. 2017. Molecular and cellular mechanisms of palate development. J Dent 
Res. 96(11):1184-1191. 
Lu FL, Hou JW, Tsai WS, Teng RJ, Yau KI, Wang TR. 1997. Tricho-rhino-phalangeal 
syndrome type ii associated with epiglottic aplasia and congenital nephrotic syndrome. J 
Formos Med Assoc. 96(3):217-221. 
Ludecke HJ, Schaper J, Meinecke P, Momeni P, Gross S, von Holtum D, Hirche H, Abramowicz 
MJ, Albrecht B, Apacik C et al. 2001. Genotypic and phenotypic spectrum in tricho-
rhino-phalangeal syndrome types i and iii. Am J Hum Genet. 68(1):81-91. 
Ludecke HJ, Wagner MJ, Nardmann J, La Pillo B, Parrish JE, Willems PJ, Haan EA, Frydman 
M, Hamers GJ, Wells DE et al. 1995. Molecular dissection of a contiguous gene 
syndrome: Localization of the genes involved in the langer-giedion syndrome. Hum Mol 
Genet. 4(1):31-36. 
Malik TH, Shoichet SA, Latham P, Kroll TG, Peters LL, Shivdasani RA. 2001. Transcriptional 
repression and developmental functions of the atypical vertebrate gata protein trps1. 
EMBO J. 20(7):1715-1725. 
Malik TH, Von Stechow D, Bronson RT, Shivdasani RA. 2002. Deletion of the gata domain of 
trps1 causes an absence of facial hair and provides new insights into the bone disorder in 
inherited tricho-rhino-phalangeal syndromes. Mol Cell Biol. 22(24):8592-8600. 
Martinez-Alvarez C, Tudela C, Perez-Miguelsanz J, O'Kane S, Puerta J, Ferguson MW. 2000. 
Medial edge epithelial cell fate during palatal fusion. Developmental biology. 
220(2):343-357. 
Mastroiacovo P, Maraschini A, Leoncini E, Mossey P, Bower C, Castilla E. 2011. Prevalence at 
birth of cleft lip with or without cleft palate: Data from the international perinatal 
database of typical oral clefts (ipdtoc). Cleft Palate Craniofac J. 48(1):66-81. 
Michikami I, Fukushi T, Honma S, Yoshioka S, Itoh S, Muragaki Y, Kurisu K, Ooshima T, 
Wakisaka S, Abe M. 2012. Trps1 is necessary for normal temporomandibular joint 
development. Cell Tissue Res. 348(1):131-140. 
Momeni P, Glockner G, Schmidt O, von Holtum D, Albrecht B, Gillessen-Kaesbach G, 
Hennekam R, Meinecke P, Zabel B, Rosenthal A et al. 2000. Mutations in a new gene, 
encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type i. Nat 
Genet. 24(1):71-74. 
Montenegro MA, Rojas M, Dominguez S, Vergara A. 2000. Cytokeratin, vimentin and e-
cadherin immunodetection in the embryonic palate in two strains of mice with different 
susceptibility to glucocorticoid-induced clefting. Journal of craniofacial genetics and 
developmental biology. 20(3):137-143. 
Morioka D, Suse T, Shimizu Y, Ohkubo F, Hosaka Y. 1999. Langer-giedion syndrome 
associated with submucous cleft palate. Plastic and reconstructive surgery. 103(5):1458-
1463. 
 43 
Napierala D, Sam K, Morello R, Zheng Q, Munivez E, Shivdasani RA, Lee B. 2008. Uncoupling 
of chondrocyte differentiation and perichondrial mineralization underlies the skeletal 
dysplasia in tricho-rhino-phalangeal syndrome. Hum Mol Genet. 17(14):2244-2254. 
Nardmann J, Tranebjaerg L, Horsthemke B, Ludecke HJ. 1997. The tricho-rhino-phalangeal 
syndromes: Frequency and parental origin of 8q deletions. Hum Genet. 99(5):638-643. 
Prevalence of cleft lip & cleft palate. 2018. [accessed]. https://www.nidcr.nih.gov/research/data-
statistics/craniofacial-birth-defects/prevalence. 
Natsume N, Kato T, Hayakawa T, Imura H, Liu SQ, Wen FJ, Chen H, Liu Y, Huang BR, Wang 
XY. 2013. Diagnostic/genetic sreening-approach for genetic diagnoses and prevention of 
cleft lip and/or palate. Chin J Dent Res. 16(2):95-100. 
Panetta NJ, Gupta DM, Slater BJ, Kwan MD, Liu KJ, Longaker MT. 2008. Tissue engineering in 
cleft palate and other congenital malformations. Pediatric Research. 63:545. 
Parada-Sanchez MT, Chu EY, Cox LL, Undurty SS, Standley JM, Murray JC, Cox TC. 2017. 
Disrupted irf6-nme1/2 complexes as a cause of cleft lip/palate. J Dent Res. 96(11):1330-
1338. 
Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, 
Collins JS, Kirby RS et al. 2010. Updated national birth prevalence estimates for selected 
birth defects in the united states, 2004-2006. Birth Defects Res A Clin Mol Teratol. 
88(12):1008-1016. 
Pelton RW, Hogan BLM, Miller DA, Moses HL. 1990. Differential expression of genes 
encoding tgfs β1, β2, and β3 during murine palate formation. Developmental biology. 
141(2):456-460. 
Pourebrahim N, Hashemibeni B, Shahnaseri S, Torabinia N, Mousavi B, Adibi S, Heidari F, 
Alavi MJ. 2013. A comparison of tissue-engineered bone from adipose-derived stem cell 
with autogenous bone repair in maxillary alveolar cleft model in dogs. International 
journal of oral and maxillofacial surgery. 42(5):562-568. 
Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW, 
Doetschman T. 1995. Transforming growth factor-beta 3 is required for secondary palate 
fusion. Nat Genet. 11(4):409-414. 
Pungchanchaikul P, Gelbier M, Ferretti P, Bloch-Zupan A. 2005. Gene expression during palate 
fusion in vivo and in vitro. J Dent Res. 84(6):526-531. 
Rice R, Connor E, Rice DP. 2006. Expression patterns of hedgehog signalling pathway members 
during mouse palate development. Gene Expr Patterns. 6(2):206-212. 
Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon AP, Dickson C, Thesleff I, Rice 
DP. 2004. Disruption of fgf10/fgfr2b-coordinated epithelial-mesenchymal interactions 
causes cleft palate. J Clin Invest. 113(12):1692-1700. 
Rienhoff HY, Yeo C-Y, Morissette R, Khrebtukova I, Melnick J, Luo S, Leng N, Kim Y-J, 
Schroth G, Westwick J et al. 2013. A mutation in tgfb3 associated with a syndrome of 
low muscle mass, growth retardation, distal arthrogryposis and clinical features 
overlapping with marfan and loeys–dietz syndrome. Am J Med Genet. 161(8):2040-2046. 
Solc R, Klugerova M, Vcelak J, Baxova A, Kuklik M, Vseticka J, Beharka R, Hirschfeldova K. 
2017. Mutation analysis of trps1 gene including core promoter, 5'utr, and 3'utr regulatory 
sequences with insight into their organization. Clin Chim Acta. 464:30-36. 
Stinson S, Lackner MR, Adai AT, Yu N, Kim HJ, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd 
Z, Januario T et al. 2011. Trps1 targeting by mir-221/222 promotes the epithelial-to-
mesenchymal transition in breast cancer. Science signaling. 4(177):ra41. 
 44 
Su P, Hu J, Zhang H, Jia M, Li W, Jing X, Zhou G. 2014. Association of trps1 gene with 
different emt markers in erα-positive and erα-negative breast cancer. Diagnostic 
Pathology. 9:119-119. 
Suemoto H, Muragaki Y, Nishioka K, Sato M, Ooshima A, Itoh S, Hatamura I, Ozaki M, Braun 
A, Gustafsson E et al. 2007. Trps1 regulates proliferation and apoptosis of chondrocytes 
through stat3 signaling. Developmental biology. 312(2):572-581. 
Tasic V, Gucev Z, Ristoska-Bojkovska N, Janchevska A, Ludecke HJ. 2014. Tricho-rhino-
phalangeal syndrome in a 13-year-old girl with chronic renal failure and severe growth 
retardation. Ren Fail. 36(4):619-622. 
Tavakolinejad S, Ebrahimzadeh Bidskan A, Ashraf H, Hamidi Alamdari D. 2014. A glance at 
methods for cleft palate repair. Iranian Red Crescent Medical Journal. 16(9):e15393. 
Taya Y, O'Kane S, Ferguson MW. 1999. Pathogenesis of cleft palate in tgf-beta3 knockout mice. 
Development (Cambridge, England). 126(17):3869-3879. 
Thiery JP, Acloque H, Huang RYJ, Nieto MA. 2009. Epithelial-mesenchymal transitions in 
development and disease. Cell. 139(5):871-890. 
Venkatesh R. 2009. Syndromes and anomalies associated with cleft. Indian J Plast Surg. 
42(Suppl):S51-S55. 
Wu C, Endo M, Yang BH, Radecki MA, Davis PF, Zoltick PW, Spivak RM, Flake AW, 
Kirschner RE, Nah HD. 2013. Intra-amniotic transient transduction of the periderm with 
a viral vector encoding tgfbeta3 prevents cleft palate in tgfbeta3(-/-) mouse embryos. Mol 
Ther. 21(1):8-17. 
Wuelling M, Kaiser FJ, Buelens LA, Braunholz D, Shivdasani RA, Depping R, Vortkamp A. 
2009. Trps1, a regulator of chondrocyte proliferation and differentiation, interacts with 
the activator form of gli3. Developmental biology. 328(1):40-53. 
Xu X, Han J, Ito Y, Bringas P, Jr., Urata MM, Chai Y. 2006. Cell autonomous requirement for 
tgfbr2 in the disappearance of medial edge epithelium during palatal fusion. 
Developmental biology. 297(1):238-248. 
Xu Y, Qin L, Sun T, Wu H, He T, Yang Z, Mo Q, Liao L, Xu J. 2016. Twist1 promotes breast 
cancer invasion and metastasis by silencing foxa1 expression. Oncogene. 36:1157. 
Yu H, Smallwood PM, Wang Y, Vidaltamayo R, Reed R, Nathans J. 2010. Frizzled 1 and 
frizzled 2 genes function in palate, ventricular septum and neural tube closure: General 
implications for tissue fusion processes. Development (Cambridge, England). 
137(21):3707-3717. 
Yu W, Kamara H, Svoboda KK. 2008. The role of twist during palate development. Dev Dyn. 
237(10):2716-2725. 
Yu W, Ruest LB, Svoboda KK. 2009. Regulation of epithelial-mesenchymal transition in palatal 
fusion. Exp Biol Med (Maywood). 234(5):483-491. 
Yu W, Zhang Y, Ruest LB, Svoboda KK. 2013. Analysis of snail1 function and regulation by 
twist1 in palatal fusion. Front Physiol. 4:12. 
Zhang Z, Song Y, Zhao X, Zhang X, Fermin C, Chen Y. 2002. Rescue of cleft palate in msx1-
deficient mice by transgenic bmp4 reveals a network of bmp and shh signaling in the 
regulation of mammalian palatogenesis. Development (Cambridge, England). 
129(17):4135-4146. 
Zhe C, Yu F, Tian J, Zheng S. 2015. Trps1 regulates biliary epithelial-mesenchymal transition 
and has roles during biliary fibrosis in liver grafts: A preliminary study. PLoS One. 
10(4):e0123233. 
